Researchers have found that certain drugs may treat spinal disc degeneration in mice. The drugs, which include a combination of dasatinib and quercetin, have been shown to delay early intervertebral disc degeneration in mouse models. It is unclear if these findings will translate to humans, but some studies suggest that senolytic therapies could potentially slow spinal disc degeneration and relieve chronic back pain.